283 related articles for article (PubMed ID: 37511127)
1. Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis.
Nirala BK; Yamamichi T; Yustein JT
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511127
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.
Patrad E; Khalighfard S; Amiriani T; Khori V; Alizadeh AM
Cell Oncol (Dordr); 2022 Dec; 45(6):1073-1117. PubMed ID: 36149600
[TBL] [Abstract][Full Text] [Related]
3. Andrographolide inhibits the growth of human osteosarcoma cells by suppressing Wnt/β-catenin, PI3K/AKT and NF-κB signaling pathways.
Huang H; Lu Q; Yuan X; Zhang P; Ye C; Wei M; Yang C; Zhang L; Huang Y; Luo X; Luo J
Chem Biol Interact; 2022 Sep; 365():110068. PubMed ID: 35917943
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
5. Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets.
Liu Y; Jiang B; Li Y; Zhang X; Wang L; Yao Y; Zhu B; Shi H; Chai X; Hu X; Zhang B; Li H
Medicine (Baltimore); 2024 Jan; 103(3):e36467. PubMed ID: 38241548
[TBL] [Abstract][Full Text] [Related]
6. RANKL blockade prevents and treats aggressive osteosarcomas.
Chen Y; Di Grappa MA; Molyneux SD; McKee TD; Waterhouse P; Penninger JM; Khokha R
Sci Transl Med; 2015 Dec; 7(317):317ra197. PubMed ID: 26659571
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms and microRNAs in Osteosarcoma Pathogenesis.
Kushlinskii NE; Fridman MV; Braga EA
Biochemistry (Mosc); 2016 Apr; 81(4):315-28. PubMed ID: 27293089
[TBL] [Abstract][Full Text] [Related]
8. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
Tan S; Chao R
Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity.
Soghli N; Ferns GA; Sadeghsoltani F; Qujeq D; Yousefi T; Vaghari-Tabari M
Biochem Pharmacol; 2022 Jul; 201():115094. PubMed ID: 35588853
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.
Ma Y; Ren Y; Han EQ; Li H; Chen D; Jacobs JJ; Gitelis S; O'Keefe RJ; Konttinen YT; Yin G; Li TF
Biochem Biophys Res Commun; 2013 Feb; 431(2):274-9. PubMed ID: 23291185
[TBL] [Abstract][Full Text] [Related]
11. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
[TBL] [Abstract][Full Text] [Related]
12. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
Li KW; Wang SH; Wei X; Hou YZ; Li ZH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
[TBL] [Abstract][Full Text] [Related]
15. Nitazoxanide inhibits osteosarcoma cells growth and metastasis by suppressing AKT/mTOR and Wnt/β-catenin signaling pathways.
Ye C; Wei M; Huang H; Wang Y; Zhang L; Yang C; Huang Y; Luo J
Biol Chem; 2022 Sep; 403(10):929-943. PubMed ID: 35946850
[TBL] [Abstract][Full Text] [Related]
16. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
Yang G; Zhang C; Wang N; Chen J
Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways.
Huang Z; Wang S; Wei H; Chen H; Shen R; Lin R; Wang X; Lan W; Lin R; Lin J
J Cell Mol Med; 2021 Sep; 25(17):8442-8453. PubMed ID: 34337852
[TBL] [Abstract][Full Text] [Related]
18. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
Du X; Yang J; Yang D; Tian W; Zhu Z
BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
[TBL] [Abstract][Full Text] [Related]
19. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J
Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891
[TBL] [Abstract][Full Text] [Related]
20. NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma.
Zhao S; Kurenbekova L; Gao Y; Roos A; Creighton CJ; Rao P; Hicks J; Man TK; Lau C; Brown AM; Jones SN; Lazar AJ; Ingram D; Lev D; Donehower LA; Yustein JT
Oncogene; 2015 Sep; 34(39):5069-79. PubMed ID: 25579177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
